The invention relates to a traditional Chinese medicine pill for treating chronic atrophic gastritis, belonging to the field of traditional Chinese medicine preparation for treating chronic atrophic gastritis. According to the characteristics of atrophic gastritis, such as deficiency of origin and excess, deficiency of spleen-qi, deficiency of stomach-yin, stagnation of Qi and blood stasis throughout the course of the disease, combined with modern pharmacological research, after many years of clinical practice, the prescription was finally formulated after many adjustments. The Astragalus membranaceus and Radix Pseudostellariae in the present invention are monarch drugs, which have the effects of invigorating vital energy and invigorating spleen and benefiting stomach. They are mainly aimed at the syndrome differentiation characteristics of spleen and stomach qi deficiency in the basic pathogenesis of atrophic gastritis. Radix Rehmanniae, Dendrobium, Wumei and Schisandra chinensis are ministerial drugs, supplemented by Panax notoginseng, Zedoary rhizome, Salvia miltiorrhiza, liquorice, and other medicines, and The spleen and stomach meridian can enhance the efficacy of the above drugs. The invention can not only quickly relieve and eliminate the symptoms of patients, but also help to improve the prognosis and reduce the occurrence of gastric cancer, with a high cure rate, and has the characteristics of simple treatment method, safety and effectiveness, low cost, convenient use and no toxic side effects.
【技术实现步骤摘要】
一种治疗慢性萎缩性胃炎的中药丸剂
本专利技术涉及一种治疗慢性萎缩性胃炎的中药丸剂,属治疗慢性萎缩性胃炎的中药制剂领域。
技术介绍
慢性萎缩性胃炎(chronicatrophicgastritis,CAG)是多种病因导致胃黏膜固有腺体数量减少或消失并且可伴有肠上皮化生、不典型增生等病理特征的一种消化系统常见疾病。该病会导致患者出现腹部胀痛、消化不良等症状。若患者未能得到有效治疗则可能会诱发严重并发症,如胃穿孔、胃出血等,不利于患者身体健康。该病的病因复杂,且病程较长,与患者饮食习惯及生活习惯存在较大关系,因此治愈难度相对较大。因其与胃癌的发生有一定的关系,让人谈萎色变。中医认为病因主要与饮食不节、进食粗糙或刺激性食物、嗜好烟酒、情志不遂、素体虚弱、劳倦内伤、用药不当、久病体虚等因素有关。上述病理因素长期作用于机体,影响脾胃升降运化功能,导致脾失健运,胃失和降。脾胃同居中焦,共司水湿运化、清浊升降,脾胃失健,则易致中焦枢机不利,机体气机升降失调,从而产生痰湿、宿食、气滞、血瘀等病理产物,这些病理产物反过来再作用于脾胃,形成恶性循环,则脾愈虚胃愈弱,最后病位由气入络,久之易致恶候。其病位在胃,与肝脾关系密切。CAG病程较长,临床常表现为本虚标实、虚实夹杂之候;本虚主要是脾胃虚弱,标实主要是气滞、痰湿、血瘀。本病属中医“胃痞”范畴,其发病以脾胃肝最为密切,以脾胃运化失常、脾胃虚弱为本,脾胃虚弱又以脾气虚,胃阴虚居多,气滞血瘀贯穿病程始终,常兼夹痰湿、热毒。因此治疗总体原则为:益气健脾、活血化瘀、清热解毒。这也是拟定本方的理论基础。1978午WH0将CAG列为胃癌的 ...
【技术保护点】
1.一种治疗慢性萎缩性胃炎的中药丸剂,其特征在于,它由下列重量份的原料药制成(单位:份):黄芪295‑305 太子参195‑205 生地黄95‑105 石斛95‑105乌梅95‑105 五味子55‑65 田三七55‑65 莪术45‑55丹参95‑105 半枝莲95‑105 蒲公英95‑105 柴胡95‑105苏梗145‑155 薏苡仁195‑205 白豆蔻95‑105 厚朴95‑105法半夏95‑105 茯苓145‑155 炒麦芽145‑155 焦山楂145‑155神曲145‑155 云母石295‑305 甘草95‑105 ;上述组方中黄芪、太子参为君药,生地黄、石斛、乌梅、五味子为臣药,田三七、莪术、丹参、半枝莲、蒲公英、柴胡、苏梗、薏苡仁、白豆蔻、厚朴、法半夏、茯苓、炒麦芽、焦山楂、神曲、云母石为佐药,甘草为使药,调和诸药,同时引药入脾胃经,增强上述药物疗效。
【技术特征摘要】
1.一种治疗慢性萎缩性胃炎的中药丸剂,其特征在于,它由下列重量份的原料药制成(单位:份):黄芪295-305太子参195-205生地黄95-105石斛95-105乌梅95-105五味子55-65田三七55-65莪术45-55丹参95-105半枝莲95-105蒲公英95-105柴胡95-105苏梗145-155薏苡仁195-205白豆蔻95-105厚朴95-105法半夏95-105茯苓145-155炒麦芽145-155焦山楂145-155神曲145-155云母石295-305甘草95-105;上述组方中黄芪、太子参为君药,生地黄、石斛、乌梅、五味子为臣药,田三七、莪术、丹参、半枝莲、蒲公英、柴胡、苏梗、薏苡仁、白豆蔻、厚朴、法半夏、茯苓、炒麦芽、焦山楂、神曲、云母石为佐药,甘草为使药,调和诸药,同时引药入脾胃经,增强上述药物疗效。2.根据权利要求1所述的一种治疗慢性萎缩性胃炎的中药丸剂,其特征在于...
【专利技术属性】
技术研发人员:张勇,翁素晶,薛峰,牟亭亭,付昌格,
申请(专利权)人:公安县中医医院,
类型:发明
国别省市:湖北,42
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。